Urologix launches transurethral thermo-ablation system:
This article was originally published in Clinica
Executive Summary
Urologix (UK) has launched its T3 targeted transurethral thermo-ablation system in Europe. The T3 microwave catheters are for treating benign prostatic hyperplasia. Clinical studies in the US and UK have shown that the system avoids some of the common complications associated with transurethral prostatic resection.